Navigation Links
Roka Bioscience to Report Second Quarter 2014 Financial Results On August 11, 2014
Date:8/4/2014

WARREN, N.J., Aug. 4, 2014 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced plans to release its financial results for the second quarter of 2014 on August 11, 2014 before the open of the financial markets.

Roka Bioscience will also host a conference call at 8:30 a.m. Eastern Time on August 11, 2014 to discuss its second quarter financial results. During the conference call, material information concerning the Company, its operations, strategies and prospects may be discussed.

To listen to the conference call live, go to http://rokabio.investorroom.com/ or dial 1-877-870-4263 for domestic callers and 1-412-317-0790 for international callers.  A replay of the conference call will be available after the completion of the call through August 18, 2014 by dialing 1-877-344-7529 domestic and 1-412-317-0088 international. An online archive of the conference call will also be available by accessing the Investors section of the company's website at http://rokabio.com.

About Roka Bioscience

Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas Detection Assays incorporate our advanced molecular technologies and are performed on our "sample-in, result-out" Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies. 

Contact:

Steve Sobieski
Chief Financial Officer (908) 605-4621 ssobieski@rokabio.com

Logo - http://photos.prnewswire.com/prnh/20140801/132739


'/>"/>
SOURCE Roka Bioscience, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M
2. Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights
3. Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results
4. Ambit Biosciences To Announce Second Quarter 2014 Financial Results
5. PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages
6. Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics Targeted Next Generation Sequencing Testing Platform
7. Attention Regado Biosciences, Inc. Investors: Regado Misled Investors According to a Recently Filed Class Action
8. Meditope Biosciences Appoints Prominent Scientific Advisory Board
9. Sangamo BioSciences to Focus on Advancing ZFP Therapeutic Pipeline at J.P. Morgan Healthcare Conference
10. Coherus Biosciences Invited to Present at 2014 J.P. Morgan Annual Healthcare Conference
11. Coherus Biosciences als Präsentator zur J.P. Morgan Annual Healthcare Conference 2014 eingeladen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... VIEW, Calif. , Dec. 8, 2016 IRIDEX ... intends to offer newly issued shares of common stock, $0.01 ... pursuant to an underwritten public offering.  The final terms of ... the time of pricing, and there can be no assurance ... IRIDEX expects to use the net proceeds it ...
(Date:12/8/2016)... global biosurgery market is expected to grow at a ... to 2021. The market is poised to reach USD ... 2016. The market is primarily driven by rising number ... spinal problems, increasing clearance of biosurgery products by regulatory ... In this report, the biosurgery market is ...
(Date:12/8/2016)... Pharmacy, Inc. (NYSE: DPLO) has been recognized by the Detroit ... Standard. To learn more about Diplomat,s career opportunities, visit ... ... ... LLC, a research firm specializing in organizational health and workplace improvement. ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 2016 , ... The West Virginia Medical Institute (WVMI) announced ... name change aligns the entire company with its existing Quality Insights branded projects ... are very proud of the achievements associated with the West Virginia Medical Institute ...
(Date:12/8/2016)... ... 08, 2016 , ... Russ DiGilio , founder and ... #QuackGivesBack campaign which supported local breast cancer organizations during National Breast Cancer Awareness ... Back initiative, and we’re very pleased with the participation in every franchisee’s ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced ... counsel and Eric Hoessel to vice president of sales. , Litsinger joined ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... version gives development continuity to its innovative Unified Instance Manager architecture, meeting ... In addition, this new version optimizes the unattended auto-dialing system without agents, ...
Breaking Medicine News(10 mins):